Alpha Cognition enrolls first patient in ZUNVEYL Phase 4 study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/10/2026

1. CSQR
2. B
3. STDN
4. SPY
5. TTWO
6. NTHI
7. RHP
8. SLN
9. ACH
10. IPH

Go back to Alpha Cognition enrolls first patient in ZUNVEYL Phase 4 study
(NASDAQ: ACOG) Delayed: 9.03 -0.1 (1.1%)
Previous Close $9.13    52 Week High $ 
Open $9.21    52 Week Low $ 
Day High $9.22    P/E N/A 
Day Low $8.89    EPS $ 
Volume 9,911